Philips POLITICAL

Target: Koninklijke Philips N.V. (Royal Philips) Research cutoff: 26 October 2026 Scope: Israel-Palestine corporate communications, territorial operations, internal governance, state relationships, financing, corporate structure, and leadership activity.

Corporate Communications & Public Stance

Official communications concerning Israel and the Middle East

In its 2024 annual report, Philips described the Middle East conflict as a source of economic and political uncertainty, while disclosing several Israeli subsidiaries primarily involved in manufacturing and research and development within Diagnosis & Treatment and Connected Care.¹

The same report described the Russia-Ukraine war’s effects on supply chains and inflation, and reported that Philips had substantially reduced its Russian operations in 2022 while maintaining certain healthcare-related activities.¹

Philips’ October 2026 Israeli recruitment material continued to advertise research and development opportunities in Haifa, including work associated with computed tomography and medical imaging technologies.²

Comparative communications and humanitarian statements

On 16 December 2022, Philips announced that the Ukrainian ambassador to the Netherlands had visited its Eindhoven innovation centre to receive a Philips EPIQ ultrasound system donated by Philips Foundation to a Ukrainian public medical institution.³

The December 2022 announcement expressly framed the donation as part of Philips’ continuing humanitarian assistance to people affected by the war in Ukraine.³

In its 2024 annual report, Philips discussed the Israeli and wider Middle Eastern situation primarily in terms of geopolitical uncertainty, operational exposure, and business continuity.¹

No public evidence identified in the reviewed sources of a comparable Philips corporate announcement specifically providing humanitarian equipment to Palestinian civilian healthcare institutions after October 2023.^{1, 3}

No public evidence identified of an official Royal Philips statement endorsing Israeli military operations, endorsing Palestinian armed groups, or advocating Israeli settlement expansion.^{1, 4}

Market framing

Philips’ Israeli careers website describes the country as a location for international research, advanced medical technology, manufacturing, and collaboration with academic institutions and start-ups.⁵

Philips identifies its Israeli R&D activities across computed tomography, image-guided therapy, oncology informatics, electrophysiology, and enterprise imaging.⁵

The company’s 2024 annual report characterises its Israeli subsidiaries as part of its international operating structure rather than identifying them as geopolitical or military partnerships.¹

Comparative public-position evidence

Philips’ December 2022 Ukrainian donation announcement and 2024 Middle East operational disclosures provide documented examples of different public communications concerning two conflict regions; these sources do not establish the complete extent of Philips’ public statements on either conflict.^{3, 1}

Exor N.V. - independently attributable public positions

2023–26 October 2026 - no public evidence identified: searches using Exor N.V. and Exor alongside Israel, Palestine, Gaza, ceasefire, Israeli settlements, humanitarian assistance and political statements did not locate a verifiable public declaration issued by Exor N.V. endorsing or opposing Israeli military operations, Israeli settlement policy, Palestinian statehood, an immediate Gaza ceasefire or the conduct of either party to the conflict.^{6, 7}

The reviewed FY2025 sustainability disclosures address general human rights, business conduct and investment governance without establishing a specific Israel-Palestine geopolitical position.⁶

The available evidence therefore supports an absence of an identified public position within the reviewed sources, rather than a conclusion that Exor has adopted political neutrality or formally decided against making a statement.^{6, 7}

No relevant statement date or continuing advocacy commitment was established.^{6, 7}

Operations in Occupied or Contested Territories

Israeli operations

Philips’ 2024 annual report explicitly confirms the presence of several Israeli subsidiaries involved mainly in research, development, and manufacturing.¹

Philips’ Israeli manufacturing website identifies a Haifa Systems Plant producing CT and advanced molecular imaging systems, and a Haifa Detection Plant involved in detector technology development and production.⁸

Philips’ Israeli research directory identifies CT and PET-CT development in Haifa, medical-imaging software development, and other specialist health-technology research operations.⁵

Philips’ October 2026 Israeli recruitment material identifies continued recruitment activity associated with research and development in Israel.²

Israeli acquisitions and business units

[pre-2020] Philips states that it completed its acquisition of Carestream Health’s healthcare information systems business in August 2019, including the Israeli Algotec research centre in Ra’anana; the operation remains described on Philips’ Israeli careers website, although its current legal organisation and staffing are not independently established by that page.⁵

Philips’ Israeli careers directory identifies KODEX-EPD electrophysiology technology in Caesarea, Volcano software development in Netanya, and oncology informatics activities in Haifa and Petah Tikva.⁵

Israeli public-health procurement - corrected procedural classification

On 25 February 2024, Rambam Medical Center published an intention-to-contract notice concerning servicing of Philips ultrasound systems, identifying Medtechnica Ltd. as the proposed sole supplier, a proposed financial scope of NIS 3,200,000, and stated engagement dates from 10 March 2024 to 9 March 2026.⁹

The publication is headed “כוונה להתקשרות” (intention to engage), describes a proposed sole-supplier engagement before the committee decision, and records an elapsed objection-submission deadline; it does not independently establish final approval, an awarded or signed contract, payment, or servicing performed.⁹

Philips independently identifies Medtechnica Ltd., located in Petah Tikva, as an Israeli healthcare business partner.¹⁰

On 17 November 2024, Tel Aviv Sourasky Medical Center published a sole-supplier exemption notice concerning servicing of a Philips CT Big Bore system, identifying Philips Electronics (Israel) Ltd. as the proposed supplier.¹¹

The November 2024 notice specifies a proposed value of USD 246,000, a proposed 36-month duration, and stated engagement dates from 4 November 2024 to 4 November 2027.¹¹

The publication is categorised “פטור” (exemption), describes an intended sole-supplier engagement, and records that the submission deadline has passed; it does not independently establish a final award decision, signed contract, payment, or actual servicing.¹¹

These procurement publications concern proposed servicing arrangements at named civilian medical institutions, and neither identifies the IDF, Israeli Ministry of Defense, or a settlement institution as the proposed purchaser.^{9, 11}

Palestinian distribution

Philips’ healthcare distributor directory lists INTERMED PAL and Intermed 1994 for Medical Equipments in Ramallah, with distribution categories covering medical imaging, monitoring, and related healthcare technologies.¹²

A separate Philips Middle East directory identifies InterMed-pal in Al-Bireh, Ramallah, and lists Arcomed at a Salah Eddin Street address in Jerusalem.¹³

The Jerusalem listing does not independently establish whether Arcomed’s premises are within occupied East Jerusalem, and the directory does not establish sales to Israeli settlements.¹³

Philips’ regional contact directory separately identifies Palestine as a service territory.¹⁴

Occupied Palestinian territories and settlements

No public evidence identified of a verified Philips-owned manufacturing facility, research centre, or corporate office within an Israeli settlement.^{1, 5, 8}

No public evidence identified of a Philips-specific settlement infrastructure contract, settlement sponsorship, or direct equipment procurement agreement with an Israeli settlement authority.^{9, 11}

No public evidence identified of a verified Philips-specific contract providing surveillance, military technology, or security infrastructure within the occupied Palestinian territories.^{1, 5}

International and regulatory scrutiny

No public evidence identified in the reviewed material establishing that Philips is a named enterprise in the UN OHCHR settlement-business database.¹

No public evidence identified in the reviewed material establishing that Philips is named as a corporate case study in UN report A/HRC/59/23, concerning the economy of occupation and genocide.¹

No public evidence identified of a Philips-specific court finding, OECD National Contact Point decision, or regulatory sanction concerning its participation in Israeli settlement activity.¹

Civil-society campaigns and boycotts

The BDS Movement’s published corporate targeting guide describes consumer-boycott, organic-boycott, and pressure-target categories, as well as broader divestment and exclusion strategies.¹⁵

No public evidence identified in the reviewed guide establishing Philips as an expressly named BDS Movement priority target.¹⁵

No public evidence identified of a Philips-specific organised divestment campaign accompanied by independently verified primary documentation of settlement activity.¹⁵

No public evidence identified of a formal Philips response to an Israel-Palestine-specific boycott campaign.¹⁵

Constructive-notice chronology - corrected procurement interpretation

The Philips CT Big Bore procurement notice was published on 17 November 2024, after the ICJ advisory opinion of 19 July 2024, and identifies a proposed engagement beginning on 4 November 2024.¹¹

The stated proposed engagement period extends to November 2027, but the notice does not independently establish that a contract was awarded or that servicing continued after the November 2024 ICC arrest warrants.¹¹

Philips’ October 2026 Israeli recruitment material independently establishes continued public recruitment activity in Israel after both reference dates.²

Internal Governance, Content & Retail Policies

Employee relations and political expression

Philips publishes general business principles covering integrity, compliance, responsible conduct, and expectations for employees and management.¹⁶

No public evidence identified of Philips dismissing, suspending, disciplining, or otherwise sanctioning employees specifically for expressing pro-Palestinian views.¹⁶

No public evidence identified of legal proceedings brought by Philips against a union or employee organisation specifically over Palestine solidarity activities.¹⁶

No public evidence identified of a Philips-specific shareholder-resolution suppression incident concerning Israel-Palestine due diligence.⁴

Israeli military leave and reservist arrangements

Philips’ Israeli careers website advertises employee benefits, professional development, flexible working arrangements, and workplace inclusion.¹⁷

No public evidence identified of a company-wide or Israeli subsidiary-specific policy providing supplementary military reservist pay beyond applicable statutory obligations.¹⁷

No public evidence identified of a Philips employee-donation matching policy specifically supporting Israeli military-welfare organisations or settlement organisations.^{17, 18}

Platform and editorial policy

Philips’ Israeli R&D directory identifies healthcare software, imaging platforms, and cloud-enabled clinical informatics technologies, including IntelliSpace-branded systems.⁵

No public evidence identified of a Philips consumer social-media platform or editorial service imposing Israel-Palestine-specific political content moderation.⁵

No public evidence identified of a Philips-specific regulatory investigation involving algorithmic suppression of Palestinian political expression.⁵

Retail, product origin, and supply-chain policies

Philips publicly identifies medical technology manufacturing facilities in Haifa, including finished imaging systems and advanced detector technologies.⁸

No public evidence identified of Philips mislabelling settlement-origin products as products of Israel or of a regulatory enforcement action concerning such labelling.⁸

No public evidence identified of a Philips-specific trade or customs proceeding concerning products manufactured in Israeli settlements.⁸

Brand Heritage & State Partnerships

Brand heritage

[pre-2020] Philips states that Gerard Philips and his father Frederik established Philips & Co. in Eindhoven in 1891 to manufacture electric incandescent lamps; the relationship to the company’s present health-technology business is historical, and the founding activity is discontinued.¹⁹

Philips’ 2026 anniversary publication describes its development from light-bulb manufacturing into diagnostic imaging and modern health technology.²⁰

The company’s present careers description identifies its mission as improving health and well-being through meaningful innovation, with a stated objective of improving 2.5 billion lives annually by 2030.²¹

No public evidence identified of Philips marketing its corporate identity through Israeli military origins, Israeli intelligence connections, or settlement development.^{19, 20}

Israeli academic and medical partnerships

In a 2026 announcement, Philips identified Sheba Medical Center in Israel among the clinical and academic partners participating in COMBINE-CT, a European research partnership involving 11 organisations across six countries.²²

Philips reported that the four-year COMBINE-CT programme has an overall budget of EUR 10 million and receives funding through the European Union’s Innovative Health Initiative alongside contributions from industrial partners.²²

The announcement names Philips and Novo Nordisk as industry partners and Sheba Medical Center as a clinical and academic participant.²²

The published announcement describes medical-imaging research and clinical validation; it does not identify military or settlement-related research objectives.²²

Government recognition and state-associated activities

On 16 December 2022, Philips publicly hosted Ukraine’s ambassador to the Netherlands at its Eindhoven innovation centre for the acceptance of a donated ultrasound system intended for a Ukrainian medical institution.³

An Israeli Ministry of Foreign Affairs procurement notice dated 25 September 2026 concerns the proposed purchase of a Philips EPIQ CVx cardiac ultrasound system through Abu Dhabi-based Atlas Medical for a medical centre in Nauru.²³

The September 2026 notice identifies Atlas Medical as the proposed supplier and gives a procurement amount of USD 111,641, so the notice establishes use of a Philips-branded product in the planned transaction without establishing Philips as the direct contractual counterparty.²³

No public evidence identified of Philips sponsoring an Israeli government public-diplomacy programme specifically promoting settlements.⁴

No public evidence identified of Philips accepting an Israel-Palestine-related governmental honour tied to advocacy for Israeli military operations or settlement policy.⁴

On 22 March 2026, Israel’s Ministry of Foreign Affairs published procurement notice 4000615381 concerning the proposed acquisition and donation of a Philips spectral CT scanner to Heim Pál Children’s Hospital in Budapest, Hungary.²⁴

The notice explicitly describes the initiative as having significant humanitarian value, states that the scanner was developed at Philips’ Haifa research and development centre and manufactured entirely in Israel, and explains that the donation would showcase Israeli innovation within Hungary’s healthcare system and generate widespread favourable attention among the Hungarian public.²⁴

The ministry cites requests from senior Hungarian government officials and the close relationship between Israel and Hungary as reasons for the initiative.²⁴

Philips Electronics (Israel) Ltd. is identified as the proposed sole supplier, with an estimated procurement value of USD 1,500,000 and a stated contractual period of 19 March to 31 May 2026.²⁴

The notice establishes the ministry’s stated humanitarian and public-diplomacy objectives and Philips Israel’s proposed commercial role; it does not independently establish that the donation was completed or that Philips formulated or endorsed the ministry’s public-diplomacy objectives.²⁴

MIXiii 2025 state-associated industry sponsorship

The MIXiii Health-Tech.IL 2025 sponsorship materials establish a publicly documented association between Philips and an Israeli technology-industry promotion initiative operating in cooperation with Israeli government institutions.^{25, 26, 27}

The beneficiary was the MIXiii conference and its organising association, Israel Advanced Technology Industries Association (IATI), which identifies itself as a nonprofit industry association rather than a government agency.^{26, 27}

IATI’s stated objectives include strengthening Israel’s technology sector, facilitating international investment and commercial relationships, and supporting national economic resilience.²⁷

The conference materials separately identify the Jerusalem Development Authority, Jerusalem Municipality and Ministry of Jerusalem and Heritage under “In Cooperation”, and the Israel Innovation Authority under “In Partnership”.²⁵

Other Israeli ministries appear under “Supported by”.²⁵

These are distinct institutional relationships: the documents establish public-sector cooperation with an industry-organised event, without identifying any of those government institutions as the direct recipient of Philips’ sponsorship.^{25, 26, 27}

The beneficiary’s declared economic-development and international-promotion objectives establish the institutional context of the sponsorship, although they do not establish that Philips endorsed specific Israeli government policies.^{25, 26, 27}

Sponsorship publicity and audience

The sponsorship’s identifiable promotional result was public brand placement within the event’s official materials.²⁵

Philips appeared among the silver sponsors alongside other international healthcare and technology companies, giving its corporate name visibility in a programme that presented Israeli health technology, encouraged international commercial engagement and displayed cooperation with Israeli public institutions.^{25, 27}

IATI subsequently reported attendance exceeding 1,700 participants from 32 countries at the March 2025 conference, demonstrating the event’s international reach.²⁶

The combined presentation associated Philips with an industry initiative that publicly promoted Israel’s technology sector and its relationships with government and development institutions.^{25, 26, 27}

The sources do not independently establish that Philips’ sponsorship caused additional attendance, investment, favourable political attitudes or measurable improvements in Israel’s international reputation.^{25, 26, 27}

No sponsor-specific audience-response, economic-impact or reputational-impact assessment was identified in the official materials reviewed.^{25, 26, 27}

Lobbying, Advocacy, Financing & Logistics

Corporate political lobbying

Philips’ corporate governance disclosures identify its compliance obligations under Dutch governance rules and applicable United States securities laws.⁴

No public evidence identified of Philips conducting lobbying specifically supporting Israeli annexation, settlement expansion, anti-BDS legislation, or military assistance to Israel.⁴

No public evidence identified of a Philips corporate political action committee making a verified contribution specifically earmarked for Israel-Palestine geopolitical advocacy.⁴

No public evidence identified of Philips holding a formal leadership position in AIPAC, CFI, FIDF, JNF/KKL, or a comparable regional political pressure organisation.⁴

Financial contributions

Philips describes Philips Foundation as a charitable organisation established in 2014 with its own Management Board, which makes final decisions concerning projects and partnerships.¹⁸

The foundation’s public description identifies healthcare access and partnerships with organisations delivering healthcare interventions as its principal activities.¹⁸

Philips Foundation’s documented December 2022 contribution to Ukraine involved a Philips EPIQ ultrasound system donated to a public institution specialising in maternal and child health.³

No public evidence identified of a verified Philips or Philips Foundation contribution to the IDF, Friends of the Israel Defense Forces, JNF/KKL, settlement organisations, Israeli reservist support funds, or military-welfare bodies.¹⁸

No public evidence identified of a donation by Philips to Regavim, Im Tirtzu, or other named organisations promoting settlement activity.¹⁸

No public evidence identified of a Philips-specific Israeli settlement fundraising campaign.¹⁸

Crisis asset mobilisation

Philips’ December 2022 announcement documents the mobilisation of a Philips ultrasound system for humanitarian assistance to Ukraine through the Philips Foundation.³

No public evidence identified of a comparable verified mobilisation of Philips-owned resources for Israeli military operations following October 2023.^{3, 18}

No public evidence identified of Philips providing free medical equipment, transportation, cloud computing services, communications infrastructure, or logistical resources directly to the IDF during the Gaza conflict.¹⁸

No public evidence identified of a Philips-specific arrangement supplying equipment or infrastructure to organisations managing Israeli settlements.¹⁸

Commercial procurement distinguished from donations - corrected

Israeli government procurement publications dated February and November 2024 identify proposed maintenance and servicing engagements concerning Philips medical imaging equipment at Rambam Medical Center and Tel Aviv Sourasky Medical Center.^{9, 11}

The Rambam notice names Medtechnica Ltd. as the proposed sole supplier, while the Sourasky exemption publication names Philips Electronics (Israel) Ltd. as the proposed sole supplier.^{9, 11}

The publications establish proposed procurement parameters and identify prospective suppliers; neither independently verifies a final contract award, executed agreement, payment, revenue receipt, or servicing performance.^{9, 11}

Neither publication describes the proposed transaction as a donation, charitable contribution, or military-welfare assistance.^{9, 11}

MIXiii sponsorship channel and beneficiaries

The official MIXiii Health-Tech.IL 2026 exhibition brochure retrospectively identifies Philips as a silver sponsor of the 2025 MIXiii Health-Tech.IL conference.²⁵

Its page headed “MIXiii 2025 Sponsors” places Philips alongside other commercial sponsors and identifies cooperation with the Jerusalem Development Authority, Jerusalem Municipality and Israel’s Ministry of Jerusalem and Heritage, together with a partnership with the Israel Innovation Authority.²⁵

The official conference materials independently confirm that the 2025 event took place on 4–5 March 2025 at the International Convention Center in Jerusalem and describe its objectives of promoting Israeli technology industries and international commercial collaboration.^{26, 27}

Philips’ disclosed sponsorship establishes financial or promotional participation in an Israeli technology-industry event involving public-sector institutions; the available records do not establish the sponsorship amount, any direct payment by Philips to government authorities, or Philips’ endorsement of Israeli government policies concerning Palestine.^{25, 26, 27}

The sponsorship channel was a named commercial sponsorship tier within an industry conference organised by IATI, with event logistics also associated with Stier Group Ltd.^{25, 26, 28}

The official materials distinguish sponsors from cooperating government bodies, institutional partners and supporting organisations.²⁵

This arrangement establishes that Philips was publicly recognised as a sponsor of an event connected to Israeli public-sector economic-development activity.^{25, 27}

It does not identify the legal contracting entity receiving Philips’ contribution, establish whether the sponsorship involved a cash payment, in-kind services or another commercial arrangement, or disclose its financial value.^{25, 26}

The reviewed records also contain no evidence that the sponsorship funds were transferred to an Israeli political party, military organisation, settlement authority or specific government public-diplomacy campaign.^{25, 26, 28}

Sponsorship recognition within an event promoting national technology industries provides evidence of commercial participation and associated promotional exposure, without establishing direct political lobbying or government-policy advocacy by Philips.^{25, 27}

Sponsorship duration and subsequent participation

The official 2026 exhibition brochure retrospectively identifies Philips as a silver sponsor of MIXiii 2025, while the 2025 conference was held on 4–5 March 2025.^{25, 26}

Separately, the official MIXiii 2026 exhibitor and sponsor catalogue, covering the conference held on 29–30 June 2026, includes an individual Philips company profile.^{29, 30}

That profile identifies Philips’ healthcare and medical-device activities, gives a Haifa business address and names Yael Charny as Philips Israel’s communications lead.²⁹

Its inclusion independently establishes a further public commercial and promotional association with the 2026 event, beyond the retrospective reproduction of the 2025 sponsorship.^{25, 29}

However, appearance in the 2026 catalogue does not by itself establish the sponsorship tier, financial consideration, contractual terms or precise form of Philips’ 2026 participation.²⁹

2025–26 October 2026 - no public evidence identified: the official 2025 sponsorship record, retrospective 2026 brochure, MIXiii 2026 conference website, 2026 exhibitor and sponsor catalogue, and IATI’s 2026 conference report were examined for a Philips-specific sponsorship renewal agreement, termination announcement, contractual expiry date, ongoing funding obligation or definitive statement establishing the duration of its sponsorship commitment.^{25, 28, 29, 30}

The 2026 catalogue confirms continued public association and participation in the event’s commercial presentation, but the reviewed material does not independently establish an equivalent 2026 silver-sponsorship commitment or a binding commitment extending into 2027.^{29, 30}

Equally, the absence of an accessible renewal agreement does not establish that the 2025 sponsorship ceased.^{25, 29, 30}

The documented position is therefore a confirmed 2025 silver sponsorship, a surviving retrospective listing, and an independently documented 2026 catalogue association, with the financial and contractual continuity unresolved.^{25, 29, 30, 28}

Exor N.V. - disclosed political expenditure and lobbying position

For the 2024 reporting year, Exor N.V. reported that it made no monetary political contributions and incurred no expenditure on politics or lobbyists; the reviewed regulatory filing record independently establishes the filing of Exor’s annual reporting but does not itself reproduce the expenditure figures.^{31, 32}

The acting entity was Exor N.V., the Dutch investment holding company and minority shareholder of Royal Philips.^{4, 32}

The reviewed disclosure identifies no political recipient, lobbying intermediary or beneficiary.^{31, 32}

The reported expenditure was zero for 1 January–31 December 2024, and consequently no contribution channel, recipient relationship or continuing political funding commitment was identified for that reporting period.^{31, 32}

This is a company-reported, entity-specific negative finding that was not independently confirmed from the full annual-report text through the accessible regulatory landing page; it does not independently establish the absence of indirect political influence through investee companies, non-monetary advocacy or undisclosed third-party activities.^{31, 32}

Exor N.V.’s FY2025 sustainability disclosures, published as part of its annual reporting, classified ESRS G1-5, concerning political influence and lobbying activities, as not material.⁶

The acting entity was Exor N.V.; the reviewed disclosure identifies no Israel-Palestine-specific lobbying recipient, state authority, political organisation, intermediary, contribution or public-policy initiative.⁶

Its reporting classification applies to FY2025 but should not be interpreted as a declaration that every conceivable political activity was absent.⁶

The reviewed disclosure establishes no continuing Israel-Palestine lobbying programme or commitment extending into 2026.⁶

The status of any unreported activity remains unknown.⁶

Exor N.V. - charitable and political-contribution controls

Exor’s 2024 corporate-governance disclosures report that its Code of Conduct prohibits charitable and political contributions used as instruments of corruption.³¹

The acting entity is Exor N.V.; the relevant channel is its internal corporate-governance and anti-bribery framework, rather than a donation to an external recipient.³¹

The Code of Conduct was amended and adopted by Exor’s Board on 10 April 2024.³¹

The prohibition does not constitute a blanket ban on lawful charitable donations, sponsorships, trade-association membership or political engagement.³¹

Accordingly, it cannot independently establish whether Exor has supported Israeli, Palestinian or international humanitarian organisations.³¹

The FY2025 sustainability disclosures continue to identify the Code of Conduct and anti-bribery arrangements as components of Exor’s governance framework, indicating that these general controls remained operative during that reporting period.⁶

2023–26 October 2026 - no public evidence identified: searches for Exor N.V. by its full corporate name and abbreviated name, combined with Israel, Palestine, Gaza, West Bank, settlements, political donations, humanitarian donations, lobbying, government partnerships, advocacy organisations and public statements, did not establish a verified Exor N.V. contribution to the Israeli government, Israeli political parties, the IDF, Friends of the Israel Defense Forces, JNF/KKL, Israeli settlement organisations, Palestinian political organisations or Palestinian humanitarian organisations.^{31, 32, 6, 7}

No substantiated Israel-Palestine-specific sponsorship, public-policy lobbying campaign, advocacy-body membership or formal partnership with a state or political-advocacy institution was identified in the accessible records examined.^{31, 32, 6, 7}

The reviewed FY2024 and FY2025 corporate reporting also provided no recipient-level evidence of such an arrangement.^{31, 6}

The absence is bounded by the searched public material and does not establish that no private or undisclosed arrangement exists.^{31, 32, 6, 7}

No commencement, termination or continuing obligation can therefore be assigned to an unverified activity.^{31, 6}

Corporate Structure & Primary Mission

Corporate foundation and mission

[pre-2020] Philips was founded in Eindhoven in 1891 by Gerard and Frederik Philips as an electrical manufacturing enterprise; its founding activities were commercial and are historical rather than ongoing operations.¹⁹

Philips’ present corporate communications identify its business purpose as improving health and well-being through meaningful innovation.²¹

Its 2024 annual report identifies Diagnosis & Treatment, Connected Care, and Personal Health within its operating structure, and describes Israeli subsidiaries primarily associated with the first two business areas.¹

Ownership and governance

Philips identifies itself as a Dutch company governed through a Board of Management and a separate Supervisory Board.⁴

On 14 August 2023, Philips confirmed that Exor had acquired a 15% minority investment in the company.⁴

The company’s published relationship agreement with Exor provides for a long-term minority shareholding of up to 20% and the right to propose a Supervisory Board member.⁴

Philips’ corporate governance website publishes its Articles of Association and the procedures governing its management and supervisory bodies.⁴

No public evidence identified of an Israeli government-held golden share, special governmental voting right, or controlling state ownership position in Royal Philips.⁴

No public evidence identified of a corporate charter provision defining support for Israeli geopolitical, military, or settlement objectives as a principal purpose of Royal Philips.⁴

Subsidiary attribution

The 2024 Philips annual report establishes several Israeli subsidiaries active mainly in manufacturing and R&D.¹

Israeli procurement publication 4000594419 identifies Philips Electronics (Israel) Ltd. as the proposed sole supplier for CT Big Bore servicing at Tel Aviv Sourasky Medical Center; the publication does not independently verify that a contract was awarded or performed.¹¹

Philips’ Israeli support page identifies Medtechnica as a business partner, while the Rambam procurement notice identifies Medtechnica as the proposed sole supplier for Philips-branded ultrasound servicing; the notice does not independently establish a completed contract.^{10, 9}

Philips’ Israeli research directory also identifies Algotec, Volcano and KODEX-EPD activities as parts of its healthcare technology operations.⁵

No public evidence identified establishing that these named entities have a documented corporate mission of advancing Israeli territorial settlement policy.^{5, 4}

Exor N.V. - attribution of shareholder and portfolio activity

Exor’s FY2025 sustainability reporting distinguishes the holding company’s governance and investment decisions from the operations of companies in which it invests.⁶

The report describes Exor’s influence through investment decisions, board participation and engagement with investee companies, while acknowledging that Exor does not directly manage their everyday operations.⁶

An Israel-related commercial, charitable or political act by a portfolio company would therefore require separate evidence of Exor’s own decision, financing, direction or endorsement before being attributed to Exor N.V. as political conduct.⁶

The reviewed disclosures do not establish such an Exor-directed Israel-Palestine political action by Royal Philips.⁶

The relevant relationship is continuing investment and governance oversight; no specific Israel-Palestine political mandate, recipient or funding channel was established.^{4, 6}

Executive & Leadership Footprint

Current leadership

Philips identifies Roy Jakobs as Chief Executive Officer and Chairman of its Board of Management, a position he has held since October 2022.³³

Philips’ management register identifies Charlotte Hanneman and Marnix van Ginneken alongside Jakobs as members of its Board of Management.³⁴

The company’s published May 2026 governance information identifies Jakobs’ reappointment and his current term extending to 2030.³⁴

Supervisory Board

Philips’ 2024 annual report identifies Feike Sijbesma as Supervisory Board Chair and lists directors with backgrounds in healthcare, telecommunications, finance, international business, and industrial management.¹

The same report identifies Peter Löscher, Chua Sock Koong, Marc Harrison and Liz Doherty among the Supervisory Board members, with their professional affiliations and prior positions.¹

No public evidence identified in the reviewed profiles establishing a current executive or Supervisory Board leadership position in an organisation specifically lobbying for Israeli settlement expansion or IDF military fundraising.^{1, 34}

Executive communications

Philips’ published biography identifies Roy Jakobs’ previous leadership responsibilities across Philips’ Personal Health, Connected Care and Middle East business activities.³³

No public evidence identified of a verified public statement by Jakobs endorsing the Gaza military campaign, Israeli annexation, or settlement expansion.³³

No public evidence identified of a verified public statement by the named Philips Supervisory Board directors advocating the displacement of Palestinian civilians or the expansion of Israeli settlements.^{1, 34}

Personal philanthropy

No public evidence identified of a substantiated personal donation by Jakobs, Hanneman, van Ginneken, or Sijbesma to FIDF, the IDF, settlement organisations, or organisations providing material support to settlement development.^{33, 34}

No public evidence identified of a family-office or personally controlled foundation donation by a named Philips director specifically financing Israeli military operations or settlement activity.^{1, 34}

Investment and institutional affiliations

Philips identifies Exor as a long-term minority shareholder with governance participation rights under the August 2023 agreement.⁴

No public evidence identified of an Israel-Palestine-specific political contribution, military-welfare donation, or settlement investment by Exor that can be directly attributed to a Philips corporate decision.^{4, 6}

No public evidence identified of a verified Philips executive personal investment in an Israeli military-surveillance or defence company undertaken on behalf of Philips.^{33, 34}

Leadership conduct after July and November 2024

Philips’ publicly available governance records establish the continued leadership of Roy Jakobs and the Board of Management during 2025–2026.³⁴

No public evidence identified of a verified Israel-Palestine political advocacy or military-fundraising act by these named principals following the July 2024 ICJ advisory opinion or November 2024 ICC arrest warrants.^{33, 34}